Robeco Institutional Asset Management’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$776K Buy
9,013
+136
+2% +$11.9K ﹤0.01% 745
2026
Q1
$803K Hold
8,877
﹤0.01% 760
2025
Q4
$798K Sell
8,877
-2,568
-22% -$243K ﹤0.01% 750
2025
Q3
$1.13M Sell
11,445
-793
-6% -$78.6K ﹤0.01% 743
2025
Q2
$1.12M Sell
12,238
-10,504
-46% -$1.02M ﹤0.01% 754
2025
Q1
$2.57M Sell
22,742
-7,063
-24% -$756K 0.01% 672
2024
Q4
$3.15M Sell
29,805
-6,882
-19% -$738K 0.01% 632
2024
Q3
$3.96M Sell
36,687
-125,363
-77% -$13.7M 0.01% 594
2024
Q2
$17.6M Sell
162,050
-71,953
-31% -$8.48M 0.04% 337
2024
Q1
$30.9M Sell
234,003
-74,529
-24% -$9.31M 0.07% 274
2023
Q4
$37.5M Sell
308,532
-110,871
-26% -$12.4M 0.09% 223
2023
Q3
$47.1M Buy
419,403
+5,149
+1% +$654K 0.13% 182
2023
Q2
$60.3M Buy
414,254
+283,880
+218% +$38.6M 0.16% 149
2023
Q1
$16.8M Buy
130,374
+44,233
+51% +$5.55M 0.05% 346
2022
Q4
$11M Sell
86,141
-3,366
-4% -$391K 0.03% 422
2022
Q3
$9.36M Buy
89,507
+15,965
+22% +$1.75M 0.03% 407
2022
Q2
$7.72M Buy
73,542
+67,553
+1,128% +$8.01M 0.02% 442
2022
Q1
$766K Sell
5,989
-7
-0.1% -$844 ﹤0.01% 729
2021
Q4
$739K Sell
5,996
-9,704
-62% -$1.27M ﹤0.01% 736
2021
Q3
$2.23M Sell
15,700
-56,963
-78% -$8.38M ﹤0.01% 644
2021
Q2
$11.3M Buy
72,663
+11,684
+19% +$1.89M 0.03% 462
2021
Q1
$9.48M Sell
60,979
-3,947
-6% -$611K 0.02% 469
2020
Q4
$9.72M Buy
64,926
+5,304
+9% +$749K 0.03% 445
2020
Q3
$7.88M Sell
59,622
-1,802
-3% -$235K 0.02% 439
2020
Q2
$7.12M Sell
61,424
-51,715
-46% -$5.96M 0.02% 472
2020
Q1
$11.1M Buy
113,139
+65,009
+135% +$8.52M 0.04% 398
2019
Q4
$6.99M Sell
48,130
-9,814
-17% -$1.35M 0.02% 550
2019
Q3
$7.72M Sell
57,944
-4,720
-8% -$610K 0.03% 520
2019
Q2
$7.16M Buy
62,664
+442
+0.7% +$51.8K 0.03% 535
2019
Q1
$7.71M Buy
62,222
+24,395
+64% +$2.77M 0.03% 514
2018
Q4
$3.81M Buy
37,827
+32,063
+556% +$3.61M 0.02% 580
2018
Q3
$736K Buy
5,764
+431
+8% +$51.2K ﹤0.01% 786
2018
Q2
$577K Buy
5,333
+59
+1% +$6.42K ﹤0.01% 801
2018
Q1
$558K Hold
5,274
﹤0.01% 802
2017
Q4
$618K Buy
5,274
+2,800
+113% +$317K ﹤0.01% 747
2017
Q3
$281K Buy
2,474
+1,067
+76% +$123K ﹤0.01% 766
2017
Q2
$175K Sell
1,407
-720
-34% -$85.4K ﹤0.01% 812
2017
Q1
$252K Sell
2,127
-49,143
-96% -$5.57M ﹤0.01% 780
2016
Q4
$5.14M Sell
51,270
-13,566
-21% -$1.45M 0.04% 370
2016
Q3
$8.19M Buy
64,836
+54,168
+508% +$6.69M 0.06% 293
2016
Q2
$1.25M Hold
10,668
0.01% 578
2016
Q1
$1.1M Buy
10,668
+3,914
+58% +$379K 0.01% 588
2015
Q4
$673K Sell
6,754
-214,966
-97% -$21M 0.01% 639
2015
Q3
$20.2M Buy
221,720
+6,064
+3% +$608K 0.15% 180
2015
Q2
$22.9M Sell
215,656
-24,640
-10% -$2.73M 0.17% 166
2015
Q1
$27.4M Sell
240,296
-28,047
-10% -$3.2M 0.21% 140
2014
Q4
$29.5M Buy
268,343
+14,868
+6% +$1.57M 0.21% 132
2014
Q3
$24.7M Buy
253,475
+12,755
+5% +$1.25M 0.18% 142
2014
Q2
$24.3M Buy
240,720
+29,556
+14% +$2.88M 0.17% 146
2014
Q1
$19.4M Buy
211,164
+205,025
+3,340% +$18.9M 0.15% 169
2013
Q4
$556K Hold
6,139
﹤0.01% 492
2013
Q3
$489K Sell
6,139
-17,613
-74% -$1.39M ﹤0.01% 505
2013
Q2
$1.73M Buy
+23,752
New +$1.78M 0.02% 388

Other funds holding ZBH

Robeco Institutional Asset Management's ZBH Position: Q2 2026 in Review

Robeco Institutional Asset Management increased its Zimmer Biomet (ZBH) stake by 1.5% in Q2 2026, buying an estimated $11.9K and bringing the position to 9,013 shares worth $776K. The position accounts for ﹤0.01% of the portfolio, ranked #745.

Robeco Institutional Asset Management first reported a position in ZBH in Q2 2013 and has held it in 53 quarters since. The position peaked at $60.3M in Q2 2023. 906 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • Robeco Institutional Asset Management held 9,013 shares of Zimmer Biomet worth $776K as of Q2 2026.
  • Robeco Institutional Asset Management bought 136 Zimmer Biomet shares in Q2 2026, an estimated $11.9K.
  • Zimmer Biomet made up ﹤0.01% of Robeco Institutional Asset Management's portfolio in Q2 2026, its #745 holding.
  • Robeco Institutional Asset Management first reported a position in Zimmer Biomet in Q2 2013 and has held it in 53 quarters since.
  • Robeco Institutional Asset Management's Zimmer Biomet position peaked at $60.3M in Q2 2023.
  • 906 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Robeco Institutional Asset Management's 13F filing for Q2 2026, filed 21 Jul 2026.